ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,101.24
      -0.29%
      US Tech 100
      21,156.80
      -0.70%
      Dow Jones
      44,424.25
      -0.32%
      Brent Oil
      77.625
      0.00%
      Bitcoin
      105,150.90
      0.40%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Oncocyte Corporation (OCX) Quote

      Oncocyte Corporation

      Oncocyte Corporation (OCX)

      NASDAQ
      2.03
      0.02
      (1.00%)
      Closed January 26 4:00PM
      Delayed by 15 minutes
      2.04
      0.01
      (0.49%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      2.03
      Bid
      2.01
      Ask
      2.10
      Volume
      12,344
      2.00 Day's Range 2.08
      1.922 52 Week Range 3.4799
      Market Cap
      34.176M
      Previous Close
      2.01
      Open
      2.00
      Last Trade
      3
      @
      2.1
      Last Trade Time
      Financial Volume
      $ 25,209
      VWAP
      2.0422
      Average Volume (3m)
      97,516
      Shares Outstanding
      16,835,247
      Dividend Yield
      -
      PE Ratio
      -1.20
      Earnings Per Share (EPS)
      -1.71
      Revenue
      7.27M
      Net Profit
      -28.72M

      About Oncocyte Corporation

      OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Show more

      Sector
      In Vitro,in Vivo Diagnostics
      Industry
      In Vitro,in Vivo Diagnostics
      Website
      www.oncocyte.com
      Headquarters
      Irvine, California, USA
      Founded
      -
      Oncocyte Corporation is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker OCX. The last closing price for Oncocyte was $2.01. Over the last year, Oncocyte shares have traded in a share price range of $ 1.922 to $ 3.4799.

      Oncocyte currently has 16,835,247 shares outstanding. The market capitalization of Oncocyte is $33.84 million. Oncocyte has a price to earnings ratio (PE ratio) of -1.20.

      Ask ADVFN Intelligence (AI)

      OCX Latest News

      More News

      Form 8-K - Current report

      January 08 2025
      Edgar (US Regulatory)

      Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

      Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill provide key regulatory and reimbursement supportWill assist business...

      January 08 2025
      GlobeNewswire Inc.

      Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

      Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific...

      January 06 2025
      GlobeNewswire Inc.

      Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

      IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief...

      December 09 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      December 09 2024
      Edgar (US Regulatory)

      Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

      IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its...

      December 04 2024
      GlobeNewswire Inc.

      Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 

      Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to...

      December 02 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 12 2024
      Edgar (US Regulatory)

      Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

      Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phaseFDA...

      November 12 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.1-4.694835680752.132.181.922819212.03791148CS
      40.063.045685279191.972.691.922636062.24689963CS
      12-1-33.003300333.033.041.922975162.46658607CS
      26-1.18-36.76012461063.213.4151.922527662.59244417CS
      52-1.27-38.48484848483.33.47991.922498082.7067574CS
      156-31.37-93.922155688633.437.61.92222479513.83739188CS
      260-67.77-97.091690544469.81251.92230583543.39972514CS

      OCX - Frequently Asked Questions (FAQ)

      What is the current Oncocyte share price?
      The current share price of Oncocyte is $ 2.03
      How many Oncocyte shares are in issue?
      Oncocyte has 16,835,247 shares in issue
      What is the market cap of Oncocyte?
      The market capitalisation of Oncocyte is USD 33.84M
      What is the 1 year trading range for Oncocyte share price?
      Oncocyte has traded in the range of $ 1.922 to $ 3.4799 during the past year
      What is the PE ratio of Oncocyte?
      The price to earnings ratio of Oncocyte is -1.2
      What is the cash to sales ratio of Oncocyte?
      The cash to sales ratio of Oncocyte is 4.73
      What is the reporting currency for Oncocyte?
      Oncocyte reports financial results in USD
      What is the latest annual turnover for Oncocyte?
      The latest annual turnover of Oncocyte is USD 7.27M
      What is the latest annual profit for Oncocyte?
      The latest annual profit of Oncocyte is USD -28.72M
      What is the registered address of Oncocyte?
      The registered address for Oncocyte is 15 CUSHING, IRVINE, CALIFORNIA, 92618
      What is the Oncocyte website address?
      The website address for Oncocyte is www.oncocyte.com
      Which industry sector does Oncocyte operate in?
      Oncocyte operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NVNINVNI Group Ltd
      $ 4.38
      (193.96%)
      		366.98M
      EVAXEvaxion Biotech AS
      $ 5.99
      (64.56%)
      		55.41M
      ELABPMGC Holdings Inc
      $ 3.0901
      (56.07%)
      		76.48M
      PCLAPicoCELA Inc
      $ 4.60
      (49.35%)
      		3.75M
      GOEVCanoo Inc
      $ 0.475
      (43.94%)
      		282.22M
      GODNUGolden Star Acquisition Corporation
      $ 3.11
      (-75.82%)
      		17.51k
      GODNGolden Star Acquisition Corporation
      $ 2.93
      (-65.67%)
      		902.76k
      NXTTNext Technology Holding Inc
      $ 1.37
      (-54.93%)
      		2.56M
      SGLYSingularity Future Technology Ltd
      $ 1.625
      (-38.45%)
      		917.77k
      WHLRLWheeler Real Estate Investment Trust Inc
      $ 90.11
      (-38.07%)
      		8
      ACONAclarion Inc
      $ 0.0557
      (28.94%)
      		811.91M
      NVNINVNI Group Ltd
      $ 4.38
      (193.96%)
      		366.98M
      RIMEAlgorhythm Holdings Inc
      $ 0.0357
      (4.69%)
      		284.97M
      GOEVCanoo Inc
      $ 0.475
      (43.94%)
      		282.22M
      NVDANVIDIA Corporation
      $ 142.62
      (-3.12%)
      		232.88M

      Discussion

      View Full Feed
      Donotunderstand Donotunderstand 6 minutes ago
      He may be right
      Congress has lost all its nerve and power -- ceding just about everything to ANY POTUS
      FNMA
      CrashOverride CrashOverride 8 minutes ago
      Go gaslight somebody else. It's not effective.
      NWBO
      Donotunderstand Donotunderstand 8 minutes ago
      DJT does not care about sales tax and other GOV entities

      But yes DJT should make profit on the options that were suggested --- that the GOV would make money DIRECTLY on by selling them

      My question then -- was --- why would the GOV make more money with options than t
      DJT
      oilin07 oilin07 10 minutes ago
      How many shares do you have? Or are you just watching?
      ALST
      againstallodds againstallodds 10 minutes ago
      LOL That post dated 2021…

      And all those shits never materialized
      GNCP
      LTListener LTListener 10 minutes ago
      I think most who are truly interested in investing and doing due diligence can read the past PR’s, the presentations linked on the outdated website, all the publications and researcher commentary associated with the assets, the interviews posted especially the CEO discussing KRM-ll-81. Some invest
      RSPI
      max mastiff max mastiff 11 minutes ago
      I like the Bills all the way 🇺🇸🦍🍺
      GVSI
      k9narc k9narc 11 minutes ago
      Here's a cut and paste on that nasty cilantro gene.......

      Does kale have the cilantro gene?

      Yes, the gene TAS2R38 is associated with both kale and cilantro, and can determine whether you like bitter greens.
      Explanation
      The TAS2R38 gene determines whethe
      glenn1919 glenn1919 12 minutes ago
      PRFX.....FNGR.....TRVG.......MULN..................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
      FNGR MULN PRFX
      eastunder eastunder 12 minutes ago
      TWLO gap 113.45

      https://www.stockscores.com/chart.asp?TickerSymbol=twlo&TimeRange=120&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=None&Band=&avgType1=SMA&movAvg1=&avgType2=SMA&movAvg2=&Indicator1=None&Indicator2=&Indicator3=&Indic
      TWLO
      100lbStriper 100lbStriper 12 minutes ago
      the kid has better moves than elvis or chuck.......... https://www.youtube.com/watch?v=2cZ1TYUK8T8&list=TLPQMjYwMTIwMjXKN4tnFRo_Dw&index=2
      Donotunderstand Donotunderstand 13 minutes ago
      In most cases nope

      I raised the question as we - here at IH - keep posting about these nominees as if they are the bottom line when they are not

      Good health to all
      FNMA
      Lakota-45 Lakota-45 13 minutes ago
      Everyone has their own way of doing things 'Art67', and the way I see it, . . .

      I consider it a privilege to be on the " Shareholder Network ", and if Ken
      wants anything posted there shared with the public, when
      the time is right, . . he will be the one to do it !!!
      WDLF
      Truth_is_a_tool Truth_is_a_tool 14 minutes ago
      Right , I’m aware of that PR but I think you’re conflating that PR with the recent one stating they hope to produce 5 tons of “finished spider silk yarn”. They didn’t say composite or blended in that most recent statement. The other PR you’re referring to means they intend to take their finished sp
      KBLB
      bas2020 bas2020 15 minutes ago
      You fail to recognize that I hold a large core position. How I look at it is... if the collusive cabal try to shake the tree and profit from their manipulations, then I'm going to play along and take some of "their" money. It's a good feeling to pocket "their" money.

      Your "take it t
      NWBO
      glenn1919 glenn1919 15 minutes ago
      goro......................muln,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=3&dy=0&id=p11960084343
      glenn1919 glenn1919 16 minutes ago
      itrg...................muln....................................https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=3&dy=0&id=p11960084343
      al44 al44 16 minutes ago
      Zero credibility-

      https://i.imgur.com/Cvpa6e6.jpg
      poguemahone poguemahone 17 minutes ago
      I think Grimmer did an excellent job in articulating the pros and cons of blarcamesine. I wish he would speak on Anavex’s behalf more often. Missling should listen to this presentation, and hopefully note the absence of the “uhhs” and “duhhs” that he is prone to making.
      AVXL
      al44 al44 17 minutes ago
      Only thing she did right-

      https://i.imgur.com/yyJ42e9.png
      FCF2020 FCF2020 18 minutes ago
      Hope you're right for once.
      XALL
      pos_stock_hoarder pos_stock_hoarder 18 minutes ago
      That too. I think this was spoofing the beginning of 2001 A Space Odyssey. I could be wrong.

      Your Recent History

      NASDAQ
      OCX
      Oncocyte
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads